Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen.
Indian J Cancer
;
1994 Mar; 31(1): 1-7
Article
in English
| IMSEAR
| ID: sea-50987
ABSTRACT
Sixty-two adults with acute lymphoblastic leukaemia (ALL) were treated with a modified BFM regimen. Forty-two (70%) achieved complete remission (CR). Twenty-one percent of all evaluable patients and 32.4 percent of complete responders are in continuous complete remission (CCR) at a median follow-up of 41 months (range 24-81 months). Long-term survival was better in T- ALL (47.1%) when compared to precursor-B ALL (4.8%) (P < 0.04).
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Asparaginase
/
Vincristine
/
Remission Induction
/
Aged
/
Female
/
Humans
/
Male
/
Prednisone
/
Leukemia-Lymphoma, Adult T-Cell
/
Antineoplastic Combined Chemotherapy Protocols
Type of study:
Observational study
/
Prognostic study
Language:
English
Journal:
Indian J Cancer
Year:
1994
Type:
Article
Similar
MEDLINE
...
LILACS
LIS